Edinburgh Royal Infirmary

Do Patients Receiving GLP-1 Receptor Agonists for Weight Loss Require Structured Dietetic Care? Lessons from Metabolic and Bariatric Surgery (MBS) Pathways

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual incretin therapies have significantly advanced obesity management by facilitating clinically significant weight loss and enhancing cardiometabolic outcomes. Nevertheless, their growing application calls fo...

Consent: Doctor, can you please do my operation?

The evolution of informed consent Globally, despite extensive written guidance, landmark legal cases, and evolving clinical practices, the landscape of informed consent remains uncertain for both patients 1 and doctors. 2 The notion of informed consent was thrust upon medicine by...